Clinical Trial Update: CHIEF-PD (CHolinesterase Inhibitor to prEvent Falls in Parkinson's Disease) [Phase 3]

View source ↗

Summary

Phase 3 trial CHIEF-PD investigating a cholinesterase inhibitor to prevent falls in Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Cholinesterase inhibitor (unspecified)

Snippet

Sponsor: University of Bristol | Conditions: Parkinson Disease | Phase 3 | Status: COMPLETED